Replimune Wins FDA Approval For Melanoma Drug After Two Previous Rejections
Product·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
The accelerated clearance follows two earlier rejections and the support of patient advocates.
Replimune
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“The accelerated clearance follows two earlier rejections and the support o”
biopharma dive — Replimune rebounds to win FDA approval of melanoma drug“The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.”
stat news — STAT+: FDA approves Replimune melanoma drug previously rejected twice